🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an extension study of secukinumab prefilled syringes in subjects w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06-19
Trial ID
NCT01544595
Treatments Being Tested
The purpose of this study was to explore the effect of treatment with 300 m...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-04
Trial ID
NCT02559622
Treatments Being Tested
The purpose of the study was to evaluate the efficacy and safety of secukin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-30
Trial ID
NCT03136861
Treatments Being Tested
The investigators aim to compare the efficacy and safety of secukinumab and...
Status
Completed
Location
First Affiliated Hospital of Fujian Medical University
Start Date
2019-07-01
Trial ID
NCT06391996
The purpose of this study was to provide 16-week efficacy, safety and toler...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-29
Trial ID
NCT02294227
Treatments Being Tested
The purpose of this study was to determine whether early intervention with ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-03-27
Trial ID
NCT03020199
Treatments Being Tested
The purpose of this research study is to find out what effects (good and ba...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-05
Trial ID
NCT04274166
Treatments Being Tested
The main objective of this study is to investigate whether controlled dose ...
Status
Completed
Location
ULB Erasme
Start Date
2020-08-20
Trial ID
NCT04340076
Treatments Being Tested
In this study, we describe our experience with secukinumab (IL-17A inhibito...
Status
Completed
Location
Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology
Start Date
2023-12-19
Trial ID
NCT07151508
The study is designed to explore the kinetics of psoriasis symptoms, prurit...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-01-04
Trial ID
NCT02362789
Treatments Being Tested